Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenario-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenario

Published:2014-09-24 Issue:1 Volume:15 Page:45-59
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Bronte Giuseppe,Sortino Giovanni,Passiglia Francesco,Rizzo Sergio,Lo Vullo Francesca,Galvano Antonio,Bazan Viviana,Rolfo Christian,Russo Antonio

Publisher

Informa Healthcare

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

http://www.tandfonline.com/doi/pdf/10.1517/14712598.2015.963052

Reference118 articles.

1. Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors

2. Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma

3. Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors

4. Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy?

5. Monoclonal antibodies in gastrointestinal cancers

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal antibodies for the treatment of non-hematological tumors: a safety review;Expert Opinion on Drug Safety;2018-11-28

2. The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet?;Critical Reviews in Oncology/Hematology;2016-11

3. Antibody Production in Plants and Green Algae;Annual Review of Plant Biology;2016-04-29

4. Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2016-03

5. PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis;Oncotarget;2016-02-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3